This action brief provides criminal justice stakeholders, correctional facility leadership, & correctional staff with helpful strategies & techniques to reduce diversion of MAT medications. The information for this brief was developed by a panel of correctional leaders & experts throughout the US.

This manual provides a starting place for jurisdictions looking to use data to better understand and improve the outcomes of people with mental and/or substance use disorders who come into contact with the criminal justice system.

This guide focuses on using medication-assisted treatment for opioid use disorder in jails and prisons and during the reentry process when justice -involved persons return to the community. It provides an overview of policies and evidence-based practices that reduce the risk of overdose and relapse.

This Joint SAMHSA-CMS informational Bulletin provides guidance to states and school systems about addressing mental health and substance use issues in schools. It provides examples of approaches for services in schools and describes some Medicaid authorities that states may use to cover services.

This action brief provides rural communities recommended strategies for adapting promising or proven interventions to better support crisis response and pre-arrest diversion in their communities. It is the first of three briefs developed from the SAMHSA Pre-Arrest Diversion Expert Panel.

This brief provides an overview of Forensic Assertive Community Treatment (FACT)—an intensive service delivery model intended for people with serious mental illness who are involved in the criminal justice system.

This report provides evidence-based practices for screening and assessment of adults in the justice system with mental illness, substance use disorders, or both. It discusses the importance of instrument selection for screening and assessment and provides detailed descriptions of recommended instruments.

This brief provides an overview of workforce issues to consider when addressing the needs of older adults living with serious mental illness (SMI). Information includes demographics; challenges faced by a provider workforce, and ideas for strengthening the geriatric workforce to address SMI.

This Guidance reviews non-pharmacologic behavioral approaches and strategies to avoid and reduce prescribing of antipsychotics whenever possible for older adults with dementia and people with intellectual and developmental disabilities.

This Guidance document gives a “bird’s eye view” of strategies to support best practice prescribing of antipsychotics for youth and summarizes the available evidence and principles to support these strategies.